nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—skin cancer—sarcoma	0.747	1	CtDrD
Imiquimod—CYP1A2—Dacarbazine—sarcoma	0.0324	0.282	CbGbCtD
Imiquimod—CYP3A4—Thiotepa—sarcoma	0.0306	0.266	CbGbCtD
Imiquimod—CYP1A2—Etoposide—sarcoma	0.0159	0.138	CbGbCtD
Imiquimod—CYP3A4—Mitoxantrone—sarcoma	0.0132	0.114	CbGbCtD
Imiquimod—CYP3A4—Vincristine—sarcoma	0.00907	0.0788	CbGbCtD
Imiquimod—CYP3A4—Etoposide—sarcoma	0.00831	0.0722	CbGbCtD
Imiquimod—CYP3A4—Doxorubicin—sarcoma	0.00567	0.0492	CbGbCtD
Imiquimod—TLR8—hematopoietic system—sarcoma	0.00393	0.155	CbGeAlD
Imiquimod—TLR8—lymphoid tissue—sarcoma	0.00277	0.109	CbGeAlD
Imiquimod—TLR8—bone marrow—sarcoma	0.00252	0.0994	CbGeAlD
Imiquimod—TLR7—hematopoietic system—sarcoma	0.00248	0.0978	CbGeAlD
Imiquimod—TLR8—liver—sarcoma	0.00204	0.0803	CbGeAlD
Imiquimod—TLR7—uterus—sarcoma	0.00187	0.0739	CbGeAlD
Imiquimod—TLR7—lymphoid tissue—sarcoma	0.00174	0.0688	CbGeAlD
Imiquimod—TLR7—tendon—sarcoma	0.00164	0.0647	CbGeAlD
Imiquimod—TLR8—lymph node—sarcoma	0.00156	0.0616	CbGeAlD
Imiquimod—TLR7—testis—sarcoma	0.00136	0.0536	CbGeAlD
Imiquimod—TLR7—liver—sarcoma	0.00128	0.0507	CbGeAlD
Imiquimod—TLR7—lymph node—sarcoma	0.000984	0.0388	CbGeAlD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—ATF1—sarcoma	0.000963	0.0503	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—ATF1—sarcoma	0.000945	0.0494	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—ATF1—sarcoma	0.000912	0.0477	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—ATF1—sarcoma	0.00073	0.0381	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—ATF1—sarcoma	0.000716	0.0374	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—ATF1—sarcoma	0.000691	0.0361	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—ATF1—sarcoma	0.000648	0.0339	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—CREB1—sarcoma	0.000522	0.0273	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—CREB1—sarcoma	0.000512	0.0268	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—CREB1—sarcoma	0.000494	0.0258	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—ATF1—sarcoma	0.000491	0.0257	CbGpPWpGaD
Imiquimod—CYP1A2—hematopoietic system—sarcoma	0.000446	0.0176	CbGeAlD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—CREB1—sarcoma	0.000395	0.0207	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—CREB1—sarcoma	0.000388	0.0203	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—sarcoma	0.000375	0.0196	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—CREB1—sarcoma	0.000375	0.0196	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—JUN—sarcoma	0.000368	0.0192	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—JUN—sarcoma	0.000355	0.0186	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—CREB1—sarcoma	0.000351	0.0184	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—JUN—sarcoma	0.000327	0.0171	CbGpPWpGaD
Imiquimod—CYP3A4—hematopoietic system—sarcoma	0.000323	0.0127	CbGeAlD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—sarcoma	0.000284	0.0149	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—JUN—sarcoma	0.000279	0.0146	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—JUN—sarcoma	0.000269	0.0141	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—CREB1—sarcoma	0.000266	0.0139	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—JUN—sarcoma	0.000255	0.0134	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—JUN—sarcoma	0.000253	0.0132	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—JUN—sarcoma	0.000248	0.013	CbGpPWpGaD
Imiquimod—CYP1A2—liver—sarcoma	0.000231	0.00912	CbGeAlD
Imiquimod—TLR8—Innate Immune System—PLCG1—sarcoma	0.000221	0.0116	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ATF1—sarcoma	0.00021	0.011	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—JUN—sarcoma	0.000194	0.0101	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—JUN—sarcoma	0.000191	0.01	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD34—sarcoma	0.000182	0.00951	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PLCG1—sarcoma	0.000168	0.00876	CbGpPWpGaD
Imiquimod—CYP3A4—liver—sarcoma	0.000167	0.0066	CbGeAlD
Imiquimod—TLR7—Innate Immune System—ATF1—sarcoma	0.000159	0.00832	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—FOXO1—sarcoma	0.000157	0.0082	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PDGFRB—sarcoma	0.000157	0.00818	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PDGFRA—sarcoma	0.000154	0.00806	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD34—sarcoma	0.000138	0.00721	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PTPRC—sarcoma	0.000132	0.00688	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	0.000131	0.00685	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	0.00013	0.00679	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PLCG1—sarcoma	0.000129	0.00673	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ATF1—sarcoma	0.000122	0.00639	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—KIT—sarcoma	0.00012	0.00625	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—FOXO1—sarcoma	0.000119	0.00621	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PDGFRB—sarcoma	0.000119	0.0062	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PDGFRA—sarcoma	0.000117	0.00611	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CREB1—sarcoma	0.000114	0.00595	CbGpPWpGaD
Imiquimod—Pain—Vincristine—sarcoma	0.000109	0.00117	CcSEcCtD
Imiquimod—Pain in extremity—Doxorubicin—sarcoma	0.000109	0.00117	CcSEcCtD
Imiquimod—Decreased appetite—Mitoxantrone—sarcoma	0.000108	0.00116	CcSEcCtD
Imiquimod—Chest pain—Etoposide—sarcoma	0.000108	0.00116	CcSEcCtD
Imiquimod—Migraine—Doxorubicin—sarcoma	0.000107	0.00115	CcSEcCtD
Imiquimod—Fatigue—Mitoxantrone—sarcoma	0.000107	0.00115	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000107	0.00115	CcSEcCtD
Imiquimod—Discomfort—Etoposide—sarcoma	0.000107	0.00114	CcSEcCtD
Imiquimod—Breast disorder—Epirubicin—sarcoma	0.000107	0.00114	CcSEcCtD
Imiquimod—Pain—Mitoxantrone—sarcoma	0.000106	0.00114	CcSEcCtD
Imiquimod—Hypersensitivity—Thiotepa—sarcoma	0.000106	0.00114	CcSEcCtD
Imiquimod—Face oedema—Doxorubicin—sarcoma	0.000105	0.00113	CcSEcCtD
Imiquimod—Hypersensitivity—Dactinomycin—sarcoma	0.000105	0.00113	CcSEcCtD
Imiquimod—Gastrointestinal pain—Vincristine—sarcoma	0.000104	0.00112	CcSEcCtD
Imiquimod—Asthenia—Thiotepa—sarcoma	0.000103	0.00111	CcSEcCtD
Imiquimod—Infection—Etoposide—sarcoma	0.000103	0.0011	CcSEcCtD
Imiquimod—Asthenia—Dactinomycin—sarcoma	0.000102	0.0011	CcSEcCtD
Imiquimod—Feeling abnormal—Mitoxantrone—sarcoma	0.000102	0.0011	CcSEcCtD
Imiquimod—Influenza—Epirubicin—sarcoma	0.000102	0.00109	CcSEcCtD
Imiquimod—Pruritus—Thiotepa—sarcoma	0.000102	0.00109	CcSEcCtD
Imiquimod—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000102	0.00109	CcSEcCtD
Imiquimod—Tachycardia—Etoposide—sarcoma	0.000101	0.00108	CcSEcCtD
Imiquimod—Body temperature increased—Vincristine—sarcoma	0.000101	0.00108	CcSEcCtD
Imiquimod—Abdominal pain—Vincristine—sarcoma	0.000101	0.00108	CcSEcCtD
Imiquimod—Skin disorder—Etoposide—sarcoma	0.0001	0.00108	CcSEcCtD
Imiquimod—Hyperhidrosis—Etoposide—sarcoma	9.99e-05	0.00107	CcSEcCtD
Imiquimod—TLR7—Immune System—PTPRC—sarcoma	9.97e-05	0.00521	CbGpPWpGaD
Imiquimod—Urticaria—Mitoxantrone—sarcoma	9.87e-05	0.00106	CcSEcCtD
Imiquimod—Breast disorder—Doxorubicin—sarcoma	9.86e-05	0.00106	CcSEcCtD
Imiquimod—Anorexia—Etoposide—sarcoma	9.85e-05	0.00106	CcSEcCtD
Imiquimod—Diarrhoea—Thiotepa—sarcoma	9.85e-05	0.00106	CcSEcCtD
Imiquimod—Body temperature increased—Mitoxantrone—sarcoma	9.82e-05	0.00106	CcSEcCtD
Imiquimod—Abdominal pain—Mitoxantrone—sarcoma	9.82e-05	0.00106	CcSEcCtD
Imiquimod—Bronchitis—Epirubicin—sarcoma	9.8e-05	0.00105	CcSEcCtD
Imiquimod—Diarrhoea—Dactinomycin—sarcoma	9.77e-05	0.00105	CcSEcCtD
Imiquimod—TLR7—Immune System—PLCG1—sarcoma	9.76e-05	0.0051	CbGpPWpGaD
Imiquimod—Pancytopenia—Epirubicin—sarcoma	9.68e-05	0.00104	CcSEcCtD
Imiquimod—Dysuria—Epirubicin—sarcoma	9.53e-05	0.00102	CcSEcCtD
Imiquimod—Dizziness—Thiotepa—sarcoma	9.52e-05	0.00102	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Epirubicin—sarcoma	9.47e-05	0.00102	CcSEcCtD
Imiquimod—Influenza—Doxorubicin—sarcoma	9.43e-05	0.00101	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—MDM2—sarcoma	9.41e-05	0.00492	CbGpPWpGaD
Imiquimod—Hypersensitivity—Vincristine—sarcoma	9.4e-05	0.00101	CcSEcCtD
Imiquimod—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	9.35e-05	0.00488	CbGpPWpGaD
Imiquimod—Photosensitivity reaction—Epirubicin—sarcoma	9.3e-05	0.000999	CcSEcCtD
Imiquimod—Paraesthesia—Etoposide—sarcoma	9.28e-05	0.000997	CcSEcCtD
Imiquimod—TLR7—Immune System—ATF1—sarcoma	9.27e-05	0.00485	CbGpPWpGaD
Imiquimod—Dyspnoea—Etoposide—sarcoma	9.22e-05	0.00099	CcSEcCtD
Imiquimod—Somnolence—Etoposide—sarcoma	9.19e-05	0.000988	CcSEcCtD
Imiquimod—Hypersensitivity—Mitoxantrone—sarcoma	9.16e-05	0.000984	CcSEcCtD
Imiquimod—Asthenia—Vincristine—sarcoma	9.16e-05	0.000984	CcSEcCtD
Imiquimod—Vomiting—Thiotepa—sarcoma	9.15e-05	0.000983	CcSEcCtD
Imiquimod—TLR8—Immune System—FOXO1—sarcoma	9.14e-05	0.00478	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PDGFRB—sarcoma	9.12e-05	0.00477	CbGpPWpGaD
Imiquimod—Infestation—Epirubicin—sarcoma	9.09e-05	0.000976	CcSEcCtD
Imiquimod—Infestation NOS—Epirubicin—sarcoma	9.09e-05	0.000976	CcSEcCtD
Imiquimod—Vomiting—Dactinomycin—sarcoma	9.08e-05	0.000976	CcSEcCtD
Imiquimod—Rash—Thiotepa—sarcoma	9.07e-05	0.000975	CcSEcCtD
Imiquimod—Bronchitis—Doxorubicin—sarcoma	9.07e-05	0.000974	CcSEcCtD
Imiquimod—Dermatitis—Thiotepa—sarcoma	9.07e-05	0.000974	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—KIT—sarcoma	9.06e-05	0.00473	CbGpPWpGaD
Imiquimod—Headache—Thiotepa—sarcoma	9.02e-05	0.000969	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Epirubicin—sarcoma	9.01e-05	0.000968	CcSEcCtD
Imiquimod—Rash—Dactinomycin—sarcoma	9.01e-05	0.000968	CcSEcCtD
Imiquimod—Decreased appetite—Etoposide—sarcoma	8.99e-05	0.000966	CcSEcCtD
Imiquimod—TLR8—Immune System—PDGFRA—sarcoma	8.98e-05	0.00469	CbGpPWpGaD
Imiquimod—Pancytopenia—Doxorubicin—sarcoma	8.95e-05	0.000962	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Etoposide—sarcoma	8.92e-05	0.000959	CcSEcCtD
Imiquimod—Asthenia—Mitoxantrone—sarcoma	8.92e-05	0.000958	CcSEcCtD
Imiquimod—Fatigue—Etoposide—sarcoma	8.91e-05	0.000958	CcSEcCtD
Imiquimod—Neuropathy peripheral—Epirubicin—sarcoma	8.91e-05	0.000957	CcSEcCtD
Imiquimod—Pain—Etoposide—sarcoma	8.84e-05	0.00095	CcSEcCtD
Imiquimod—Urinary tract infection—Epirubicin—sarcoma	8.83e-05	0.000949	CcSEcCtD
Imiquimod—Conjunctivitis—Epirubicin—sarcoma	8.83e-05	0.000949	CcSEcCtD
Imiquimod—Dysuria—Doxorubicin—sarcoma	8.82e-05	0.000947	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Doxorubicin—sarcoma	8.76e-05	0.000942	CcSEcCtD
Imiquimod—Diarrhoea—Vincristine—sarcoma	8.73e-05	0.000938	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CREB1—sarcoma	8.62e-05	0.00451	CbGpPWpGaD
Imiquimod—Photosensitivity reaction—Doxorubicin—sarcoma	8.61e-05	0.000925	CcSEcCtD
Imiquimod—Hepatobiliary disease—Epirubicin—sarcoma	8.59e-05	0.000923	CcSEcCtD
Imiquimod—Nausea—Thiotepa—sarcoma	8.55e-05	0.000919	CcSEcCtD
Imiquimod—Sinusitis—Epirubicin—sarcoma	8.52e-05	0.000916	CcSEcCtD
Imiquimod—Feeling abnormal—Etoposide—sarcoma	8.52e-05	0.000915	CcSEcCtD
Imiquimod—Diarrhoea—Mitoxantrone—sarcoma	8.5e-05	0.000914	CcSEcCtD
Imiquimod—Nausea—Dactinomycin—sarcoma	8.48e-05	0.000912	CcSEcCtD
Imiquimod—Gastrointestinal pain—Etoposide—sarcoma	8.45e-05	0.000908	CcSEcCtD
Imiquimod—Dizziness—Vincristine—sarcoma	8.44e-05	0.000907	CcSEcCtD
Imiquimod—Infestation NOS—Doxorubicin—sarcoma	8.41e-05	0.000903	CcSEcCtD
Imiquimod—Infestation—Doxorubicin—sarcoma	8.41e-05	0.000903	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Doxorubicin—sarcoma	8.33e-05	0.000896	CcSEcCtD
Imiquimod—Neuropathy peripheral—Doxorubicin—sarcoma	8.24e-05	0.000885	CcSEcCtD
Imiquimod—Urticaria—Etoposide—sarcoma	8.21e-05	0.000882	CcSEcCtD
Imiquimod—Haemoglobin—Epirubicin—sarcoma	8.2e-05	0.000881	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—JUN—sarcoma	8.18e-05	0.00428	CbGpPWpGaD
Imiquimod—Rhinitis—Epirubicin—sarcoma	8.18e-05	0.000879	CcSEcCtD
Imiquimod—Abdominal pain—Etoposide—sarcoma	8.17e-05	0.000878	CcSEcCtD
Imiquimod—Body temperature increased—Etoposide—sarcoma	8.17e-05	0.000878	CcSEcCtD
Imiquimod—Urinary tract infection—Doxorubicin—sarcoma	8.17e-05	0.000878	CcSEcCtD
Imiquimod—Conjunctivitis—Doxorubicin—sarcoma	8.17e-05	0.000878	CcSEcCtD
Imiquimod—Haemorrhage—Epirubicin—sarcoma	8.16e-05	0.000876	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CTNNB1—sarcoma	8.12e-05	0.00424	CbGpPWpGaD
Imiquimod—Vomiting—Vincristine—sarcoma	8.11e-05	0.000872	CcSEcCtD
Imiquimod—Pharyngitis—Epirubicin—sarcoma	8.09e-05	0.00087	CcSEcCtD
Imiquimod—Urinary tract disorder—Epirubicin—sarcoma	8.05e-05	0.000866	CcSEcCtD
Imiquimod—Rash—Vincristine—sarcoma	8.05e-05	0.000865	CcSEcCtD
Imiquimod—Dermatitis—Vincristine—sarcoma	8.04e-05	0.000864	CcSEcCtD
Imiquimod—Connective tissue disorder—Epirubicin—sarcoma	8.01e-05	0.000861	CcSEcCtD
Imiquimod—Urethral disorder—Epirubicin—sarcoma	8e-05	0.000859	CcSEcCtD
Imiquimod—Headache—Vincristine—sarcoma	7.99e-05	0.000859	CcSEcCtD
Imiquimod—Hepatobiliary disease—Doxorubicin—sarcoma	7.95e-05	0.000854	CcSEcCtD
Imiquimod—Vomiting—Mitoxantrone—sarcoma	7.9e-05	0.000849	CcSEcCtD
Imiquimod—Sinusitis—Doxorubicin—sarcoma	7.89e-05	0.000847	CcSEcCtD
Imiquimod—Visual impairment—Epirubicin—sarcoma	7.86e-05	0.000845	CcSEcCtD
Imiquimod—Rash—Mitoxantrone—sarcoma	7.84e-05	0.000842	CcSEcCtD
Imiquimod—Dermatitis—Mitoxantrone—sarcoma	7.83e-05	0.000841	CcSEcCtD
Imiquimod—Headache—Mitoxantrone—sarcoma	7.79e-05	0.000837	CcSEcCtD
Imiquimod—Erythema multiforme—Epirubicin—sarcoma	7.71e-05	0.000829	CcSEcCtD
Imiquimod—Eye disorder—Epirubicin—sarcoma	7.62e-05	0.000819	CcSEcCtD
Imiquimod—Hypersensitivity—Etoposide—sarcoma	7.62e-05	0.000818	CcSEcCtD
Imiquimod—Tinnitus—Epirubicin—sarcoma	7.6e-05	0.000817	CcSEcCtD
Imiquimod—Haemoglobin—Doxorubicin—sarcoma	7.59e-05	0.000815	CcSEcCtD
Imiquimod—Nausea—Vincristine—sarcoma	7.58e-05	0.000815	CcSEcCtD
Imiquimod—Flushing—Epirubicin—sarcoma	7.57e-05	0.000813	CcSEcCtD
Imiquimod—Rhinitis—Doxorubicin—sarcoma	7.57e-05	0.000813	CcSEcCtD
Imiquimod—Haemorrhage—Doxorubicin—sarcoma	7.55e-05	0.000811	CcSEcCtD
Imiquimod—Pharyngitis—Doxorubicin—sarcoma	7.49e-05	0.000805	CcSEcCtD
Imiquimod—Urinary tract disorder—Doxorubicin—sarcoma	7.45e-05	0.000801	CcSEcCtD
Imiquimod—Asthenia—Etoposide—sarcoma	7.42e-05	0.000797	CcSEcCtD
Imiquimod—Connective tissue disorder—Doxorubicin—sarcoma	7.42e-05	0.000797	CcSEcCtD
Imiquimod—Angiopathy—Epirubicin—sarcoma	7.4e-05	0.000795	CcSEcCtD
Imiquimod—Urethral disorder—Doxorubicin—sarcoma	7.4e-05	0.000795	CcSEcCtD
Imiquimod—Nausea—Mitoxantrone—sarcoma	7.38e-05	0.000793	CcSEcCtD
Imiquimod—Immune system disorder—Epirubicin—sarcoma	7.37e-05	0.000792	CcSEcCtD
Imiquimod—Mediastinal disorder—Epirubicin—sarcoma	7.35e-05	0.00079	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—SRC—sarcoma	7.34e-05	0.00384	CbGpPWpGaD
Imiquimod—Chills—Epirubicin—sarcoma	7.32e-05	0.000786	CcSEcCtD
Imiquimod—Pruritus—Etoposide—sarcoma	7.31e-05	0.000786	CcSEcCtD
Imiquimod—Arrhythmia—Epirubicin—sarcoma	7.29e-05	0.000783	CcSEcCtD
Imiquimod—Visual impairment—Doxorubicin—sarcoma	7.27e-05	0.000781	CcSEcCtD
Imiquimod—Alopecia—Epirubicin—sarcoma	7.21e-05	0.000774	CcSEcCtD
Imiquimod—Mental disorder—Epirubicin—sarcoma	7.15e-05	0.000768	CcSEcCtD
Imiquimod—Erythema multiforme—Doxorubicin—sarcoma	7.14e-05	0.000767	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—MDM2—sarcoma	7.13e-05	0.00373	CbGpPWpGaD
Imiquimod—Malnutrition—Epirubicin—sarcoma	7.1e-05	0.000763	CcSEcCtD
Imiquimod—Erythema—Epirubicin—sarcoma	7.1e-05	0.000763	CcSEcCtD
Imiquimod—Diarrhoea—Etoposide—sarcoma	7.07e-05	0.00076	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—NRAS—sarcoma	7.06e-05	0.00369	CbGpPWpGaD
Imiquimod—Eye disorder—Doxorubicin—sarcoma	7.05e-05	0.000758	CcSEcCtD
Imiquimod—Tinnitus—Doxorubicin—sarcoma	7.04e-05	0.000756	CcSEcCtD
Imiquimod—Flushing—Doxorubicin—sarcoma	7e-05	0.000753	CcSEcCtD
Imiquimod—TLR8—Immune System—KIT—sarcoma	6.96e-05	0.00364	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FOXO1—sarcoma	6.92e-05	0.00362	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PDGFRB—sarcoma	6.91e-05	0.00361	CbGpPWpGaD
Imiquimod—Back pain—Epirubicin—sarcoma	6.87e-05	0.000738	CcSEcCtD
Imiquimod—Angiopathy—Doxorubicin—sarcoma	6.85e-05	0.000736	CcSEcCtD
Imiquimod—Dizziness—Etoposide—sarcoma	6.84e-05	0.000735	CcSEcCtD
Imiquimod—Immune system disorder—Doxorubicin—sarcoma	6.82e-05	0.000732	CcSEcCtD
Imiquimod—TLR7—Immune System—PDGFRA—sarcoma	6.8e-05	0.00356	CbGpPWpGaD
Imiquimod—Mediastinal disorder—Doxorubicin—sarcoma	6.8e-05	0.000731	CcSEcCtD
Imiquimod—Chills—Doxorubicin—sarcoma	6.77e-05	0.000728	CcSEcCtD
Imiquimod—Arrhythmia—Doxorubicin—sarcoma	6.74e-05	0.000724	CcSEcCtD
Imiquimod—Alopecia—Doxorubicin—sarcoma	6.67e-05	0.000717	CcSEcCtD
Imiquimod—TLR8—Immune System—CREB1—sarcoma	6.63e-05	0.00346	CbGpPWpGaD
Imiquimod—Mental disorder—Doxorubicin—sarcoma	6.61e-05	0.00071	CcSEcCtD
Imiquimod—Ill-defined disorder—Epirubicin—sarcoma	6.59e-05	0.000708	CcSEcCtD
Imiquimod—Vomiting—Etoposide—sarcoma	6.57e-05	0.000706	CcSEcCtD
Imiquimod—Erythema—Doxorubicin—sarcoma	6.57e-05	0.000706	CcSEcCtD
Imiquimod—Malnutrition—Doxorubicin—sarcoma	6.57e-05	0.000706	CcSEcCtD
Imiquimod—Agitation—Epirubicin—sarcoma	6.52e-05	0.000701	CcSEcCtD
Imiquimod—Rash—Etoposide—sarcoma	6.52e-05	0.0007	CcSEcCtD
Imiquimod—Dermatitis—Etoposide—sarcoma	6.51e-05	0.0007	CcSEcCtD
Imiquimod—Headache—Etoposide—sarcoma	6.48e-05	0.000696	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—EGFR—sarcoma	6.43e-05	0.00336	CbGpPWpGaD
Imiquimod—Malaise—Epirubicin—sarcoma	6.4e-05	0.000688	CcSEcCtD
Imiquimod—Syncope—Epirubicin—sarcoma	6.37e-05	0.000684	CcSEcCtD
Imiquimod—Back pain—Doxorubicin—sarcoma	6.35e-05	0.000683	CcSEcCtD
Imiquimod—Palpitations—Epirubicin—sarcoma	6.27e-05	0.000674	CcSEcCtD
Imiquimod—Loss of consciousness—Epirubicin—sarcoma	6.24e-05	0.000671	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—JUN—sarcoma	6.2e-05	0.00324	CbGpPWpGaD
Imiquimod—Cough—Epirubicin—sarcoma	6.2e-05	0.000666	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CTNNB1—sarcoma	6.15e-05	0.00322	CbGpPWpGaD
Imiquimod—Convulsion—Epirubicin—sarcoma	6.15e-05	0.000661	CcSEcCtD
Imiquimod—Nausea—Etoposide—sarcoma	6.14e-05	0.00066	CcSEcCtD
Imiquimod—Hypertension—Epirubicin—sarcoma	6.13e-05	0.000659	CcSEcCtD
Imiquimod—Ill-defined disorder—Doxorubicin—sarcoma	6.1e-05	0.000655	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—KRAS—sarcoma	6.08e-05	0.00318	CbGpPWpGaD
Imiquimod—Arthralgia—Epirubicin—sarcoma	6.04e-05	0.00065	CcSEcCtD
Imiquimod—Chest pain—Epirubicin—sarcoma	6.04e-05	0.00065	CcSEcCtD
Imiquimod—Myalgia—Epirubicin—sarcoma	6.04e-05	0.00065	CcSEcCtD
Imiquimod—Agitation—Doxorubicin—sarcoma	6.04e-05	0.000649	CcSEcCtD
Imiquimod—Anxiety—Epirubicin—sarcoma	6.02e-05	0.000647	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	6e-05	0.000645	CcSEcCtD
Imiquimod—Discomfort—Epirubicin—sarcoma	5.97e-05	0.000642	CcSEcCtD
Imiquimod—Malaise—Doxorubicin—sarcoma	5.92e-05	0.000637	CcSEcCtD
Imiquimod—Dry mouth—Epirubicin—sarcoma	5.91e-05	0.000635	CcSEcCtD
Imiquimod—Syncope—Doxorubicin—sarcoma	5.89e-05	0.000633	CcSEcCtD
Imiquimod—Palpitations—Doxorubicin—sarcoma	5.81e-05	0.000624	CcSEcCtD
Imiquimod—Oedema—Epirubicin—sarcoma	5.79e-05	0.000623	CcSEcCtD
Imiquimod—Loss of consciousness—Doxorubicin—sarcoma	5.77e-05	0.00062	CcSEcCtD
Imiquimod—Infection—Epirubicin—sarcoma	5.76e-05	0.000619	CcSEcCtD
Imiquimod—Cough—Doxorubicin—sarcoma	5.73e-05	0.000616	CcSEcCtD
Imiquimod—Shock—Epirubicin—sarcoma	5.7e-05	0.000613	CcSEcCtD
Imiquimod—Convulsion—Doxorubicin—sarcoma	5.69e-05	0.000612	CcSEcCtD
Imiquimod—Nervous system disorder—Epirubicin—sarcoma	5.68e-05	0.000611	CcSEcCtD
Imiquimod—Hypertension—Doxorubicin—sarcoma	5.67e-05	0.000609	CcSEcCtD
Imiquimod—Tachycardia—Epirubicin—sarcoma	5.66e-05	0.000608	CcSEcCtD
Imiquimod—Skin disorder—Epirubicin—sarcoma	5.63e-05	0.000605	CcSEcCtD
Imiquimod—Hyperhidrosis—Epirubicin—sarcoma	5.6e-05	0.000602	CcSEcCtD
Imiquimod—Myalgia—Doxorubicin—sarcoma	5.59e-05	0.000601	CcSEcCtD
Imiquimod—Chest pain—Doxorubicin—sarcoma	5.59e-05	0.000601	CcSEcCtD
Imiquimod—Arthralgia—Doxorubicin—sarcoma	5.59e-05	0.000601	CcSEcCtD
Imiquimod—Anxiety—Doxorubicin—sarcoma	5.57e-05	0.000599	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—SRC—sarcoma	5.56e-05	0.00291	CbGpPWpGaD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	5.55e-05	0.000597	CcSEcCtD
Imiquimod—Discomfort—Doxorubicin—sarcoma	5.53e-05	0.000594	CcSEcCtD
Imiquimod—Anorexia—Epirubicin—sarcoma	5.52e-05	0.000594	CcSEcCtD
Imiquimod—TLR8—Immune System—MDM2—sarcoma	5.48e-05	0.00287	CbGpPWpGaD
Imiquimod—Dry mouth—Doxorubicin—sarcoma	5.47e-05	0.000588	CcSEcCtD
Imiquimod—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	5.44e-05	0.00284	CbGpPWpGaD
Imiquimod—Oedema—Doxorubicin—sarcoma	5.36e-05	0.000576	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—NRAS—sarcoma	5.35e-05	0.0028	CbGpPWpGaD
Imiquimod—Infection—Doxorubicin—sarcoma	5.33e-05	0.000572	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Epirubicin—sarcoma	5.28e-05	0.000567	CcSEcCtD
Imiquimod—TLR7—Immune System—KIT—sarcoma	5.28e-05	0.00276	CbGpPWpGaD
Imiquimod—Shock—Doxorubicin—sarcoma	5.27e-05	0.000567	CcSEcCtD
Imiquimod—Nervous system disorder—Doxorubicin—sarcoma	5.26e-05	0.000565	CcSEcCtD
Imiquimod—Insomnia—Epirubicin—sarcoma	5.24e-05	0.000563	CcSEcCtD
Imiquimod—Tachycardia—Doxorubicin—sarcoma	5.23e-05	0.000562	CcSEcCtD
Imiquimod—Skin disorder—Doxorubicin—sarcoma	5.21e-05	0.00056	CcSEcCtD
Imiquimod—Paraesthesia—Epirubicin—sarcoma	5.2e-05	0.000559	CcSEcCtD
Imiquimod—Hyperhidrosis—Doxorubicin—sarcoma	5.18e-05	0.000557	CcSEcCtD
Imiquimod—Dyspnoea—Epirubicin—sarcoma	5.17e-05	0.000555	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—HRAS—sarcoma	5.17e-05	0.0027	CbGpPWpGaD
Imiquimod—Somnolence—Epirubicin—sarcoma	5.15e-05	0.000554	CcSEcCtD
Imiquimod—Anorexia—Doxorubicin—sarcoma	5.11e-05	0.000549	CcSEcCtD
Imiquimod—Dyspepsia—Epirubicin—sarcoma	5.1e-05	0.000548	CcSEcCtD
Imiquimod—Decreased appetite—Epirubicin—sarcoma	5.04e-05	0.000541	CcSEcCtD
Imiquimod—TLR7—Immune System—CREB1—sarcoma	5.02e-05	0.00262	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Epirubicin—sarcoma	5e-05	0.000538	CcSEcCtD
Imiquimod—Fatigue—Epirubicin—sarcoma	5e-05	0.000537	CcSEcCtD
Imiquimod—Pain—Epirubicin—sarcoma	4.96e-05	0.000532	CcSEcCtD
Imiquimod—TLR8—Immune System—IL2—sarcoma	4.9e-05	0.00256	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Doxorubicin—sarcoma	4.88e-05	0.000525	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—EGFR—sarcoma	4.88e-05	0.00255	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	4.86e-05	0.00254	CbGpPWpGaD
Imiquimod—Insomnia—Doxorubicin—sarcoma	4.85e-05	0.000521	CcSEcCtD
Imiquimod—Paraesthesia—Doxorubicin—sarcoma	4.81e-05	0.000517	CcSEcCtD
Imiquimod—Dyspnoea—Doxorubicin—sarcoma	4.78e-05	0.000514	CcSEcCtD
Imiquimod—Feeling abnormal—Epirubicin—sarcoma	4.78e-05	0.000513	CcSEcCtD
Imiquimod—Somnolence—Doxorubicin—sarcoma	4.77e-05	0.000512	CcSEcCtD
Imiquimod—TLR8—Immune System—JUN—sarcoma	4.77e-05	0.00249	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Epirubicin—sarcoma	4.74e-05	0.000509	CcSEcCtD
Imiquimod—TLR8—Immune System—CTNNB1—sarcoma	4.73e-05	0.00247	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	4.72e-05	0.00247	CbGpPWpGaD
Imiquimod—Dyspepsia—Doxorubicin—sarcoma	4.72e-05	0.000507	CcSEcCtD
Imiquimod—Decreased appetite—Doxorubicin—sarcoma	4.66e-05	0.000501	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Doxorubicin—sarcoma	4.63e-05	0.000497	CcSEcCtD
Imiquimod—Fatigue—Doxorubicin—sarcoma	4.62e-05	0.000497	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—KRAS—sarcoma	4.61e-05	0.00241	CbGpPWpGaD
Imiquimod—Urticaria—Epirubicin—sarcoma	4.6e-05	0.000495	CcSEcCtD
Imiquimod—Pain—Doxorubicin—sarcoma	4.58e-05	0.000493	CcSEcCtD
Imiquimod—Body temperature increased—Epirubicin—sarcoma	4.58e-05	0.000492	CcSEcCtD
Imiquimod—Abdominal pain—Epirubicin—sarcoma	4.58e-05	0.000492	CcSEcCtD
Imiquimod—Feeling abnormal—Doxorubicin—sarcoma	4.42e-05	0.000475	CcSEcCtD
Imiquimod—Gastrointestinal pain—Doxorubicin—sarcoma	4.38e-05	0.000471	CcSEcCtD
Imiquimod—TLR8—Immune System—SRC—sarcoma	4.27e-05	0.00223	CbGpPWpGaD
Imiquimod—Hypersensitivity—Epirubicin—sarcoma	4.27e-05	0.000459	CcSEcCtD
Imiquimod—Urticaria—Doxorubicin—sarcoma	4.26e-05	0.000458	CcSEcCtD
Imiquimod—Abdominal pain—Doxorubicin—sarcoma	4.24e-05	0.000455	CcSEcCtD
Imiquimod—Body temperature increased—Doxorubicin—sarcoma	4.24e-05	0.000455	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	4.24e-05	0.00221	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	4.24e-05	0.00221	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	4.19e-05	0.00219	CbGpPWpGaD
Imiquimod—Asthenia—Epirubicin—sarcoma	4.16e-05	0.000447	CcSEcCtD
Imiquimod—TLR7—Immune System—MDM2—sarcoma	4.15e-05	0.00217	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	4.13e-05	0.00216	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NRAS—sarcoma	4.11e-05	0.00215	CbGpPWpGaD
Imiquimod—Pruritus—Epirubicin—sarcoma	4.1e-05	0.000441	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	4.08e-05	0.00213	CbGpPWpGaD
Imiquimod—Diarrhoea—Epirubicin—sarcoma	3.96e-05	0.000426	CcSEcCtD
Imiquimod—Hypersensitivity—Doxorubicin—sarcoma	3.95e-05	0.000424	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—HRAS—sarcoma	3.91e-05	0.00205	CbGpPWpGaD
Imiquimod—Asthenia—Doxorubicin—sarcoma	3.85e-05	0.000413	CcSEcCtD
Imiquimod—Dizziness—Epirubicin—sarcoma	3.83e-05	0.000412	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	3.8e-05	0.00198	CbGpPWpGaD
Imiquimod—Pruritus—Doxorubicin—sarcoma	3.79e-05	0.000408	CcSEcCtD
Imiquimod—TLR8—Immune System—EGFR—sarcoma	3.75e-05	0.00196	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	3.71e-05	0.00194	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	3.71e-05	0.00194	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL2—sarcoma	3.71e-05	0.00194	CbGpPWpGaD
Imiquimod—Vomiting—Epirubicin—sarcoma	3.68e-05	0.000396	CcSEcCtD
Imiquimod—Diarrhoea—Doxorubicin—sarcoma	3.67e-05	0.000394	CcSEcCtD
Imiquimod—Rash—Epirubicin—sarcoma	3.65e-05	0.000393	CcSEcCtD
Imiquimod—Dermatitis—Epirubicin—sarcoma	3.65e-05	0.000392	CcSEcCtD
Imiquimod—Headache—Epirubicin—sarcoma	3.63e-05	0.00039	CcSEcCtD
Imiquimod—TLR7—Immune System—JUN—sarcoma	3.61e-05	0.00189	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CTNNB1—sarcoma	3.58e-05	0.00187	CbGpPWpGaD
Imiquimod—Dizziness—Doxorubicin—sarcoma	3.55e-05	0.000381	CcSEcCtD
Imiquimod—TLR8—Immune System—KRAS—sarcoma	3.54e-05	0.00185	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	3.51e-05	0.00183	CbGpPWpGaD
Imiquimod—Nausea—Epirubicin—sarcoma	3.44e-05	0.00037	CcSEcCtD
Imiquimod—Vomiting—Doxorubicin—sarcoma	3.41e-05	0.000366	CcSEcCtD
Imiquimod—Rash—Doxorubicin—sarcoma	3.38e-05	0.000363	CcSEcCtD
Imiquimod—Dermatitis—Doxorubicin—sarcoma	3.38e-05	0.000363	CcSEcCtD
Imiquimod—Headache—Doxorubicin—sarcoma	3.36e-05	0.000361	CcSEcCtD
Imiquimod—TLR7—Immune System—SRC—sarcoma	3.24e-05	0.00169	CbGpPWpGaD
Imiquimod—Nausea—Doxorubicin—sarcoma	3.18e-05	0.000342	CcSEcCtD
Imiquimod—TLR7—Immune System—NRAS—sarcoma	3.12e-05	0.00163	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HRAS—sarcoma	3.01e-05	0.00157	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	2.98e-05	0.00156	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EGFR—sarcoma	2.84e-05	0.00148	CbGpPWpGaD
Imiquimod—TLR7—Immune System—KRAS—sarcoma	2.68e-05	0.0014	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HRAS—sarcoma	2.28e-05	0.00119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ENO2—sarcoma	8.96e-06	0.000468	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HBA1—sarcoma	8.9e-06	0.000465	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLCG1—sarcoma	7.6e-06	0.000397	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ENO2—sarcoma	6.91e-06	0.000361	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HBA1—sarcoma	6.87e-06	0.000359	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLCG1—sarcoma	5.87e-06	0.000307	CbGpPWpGaD
